Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (13411)	10/7/2004 4:28:15 PM
From: scaram(o)uche	Read Replies (3) \| Respond to of 52153

>> at end of slow day << You live on the slopes of Mt. St. Helens and have a short-term, "relative" perspective? I'm largely in cash, so a very small part of me understands that today was good, but.... the average stock that I do own? It took a good beating today. What's the damage to pharma and biotech -- total capitalization -- from the spotlight on by a single Merck product? Rumor and fear mongers out and about, it's fun to watch. A CNBC reporter was commenting, right around the close, that JNJ took a hit... sounded like the Centocor anti-TNF and B lymphoma story. People running stocks/options around by whatever works. I'd say that Joe Kernan, on CNBC, said "Topol" twenty seven thousand times today, give or take.